natgillin/translations-raw huggingface dataset:
General disorders and administration site conditions Injection site reactions include redness, pain, itching, hives, swelling, or inflammation.
Splošne težave in spremembe na mestu aplikacije Reakcije na mestu injiciranja so pordelost, bolečine, srbenje, urtikarija, otekanje ali vnetje.
Cartridges in use (in the insulin pen) or carried as a spare may be stored for a maximum of 4 weeks not above 30°C and away from direct heat or direct light.
Vložke, ki jih uporabljate (v insulinskem injekcijskem peresniku) ali jih imate pri sebi za rezervo, lahko shranjujete največ 4 tedne pri temperaturi do 30°C in zaščitene pred neposredno toploto ali svetlobo.
Plasma “trough” levels of insulin glargine and its main M1 and M2 metabolites were measured in children treated with insulin glargine, revealing plasma concentration patterns similar to adults, and providing no evidence for accumulation of insulin glargine or its metabolites with chronic dosing.
»Najnižje« plazemske ravni insulina glargin in njegovih glavnih metabolitov, M1 in M2, so bile izmerjene pri otrocih, zdravljenih z insulinom glargin - plazemske koncentracije so podobne kot pri odraslih.
To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment.
Bolniki, ki z insulina NPH dvakrat na dan preidejo na zdravilo Lantus enkrat na dan, morajo za zmanjšanje nevarnosti nočne in zgodnje jutranje hipoglikemije dnevni odmerek bazalnega insulina v prvih tednih zdravljenja z zdravilom Lantus zmanjšati za 20 do 30%.
Method of administration Lantus is administered subcutaneously.
Zdravilo Lantus se daje subkutano.
There are no clinically relevant differences in serum insulin or glucose levels after abdominal, deltoid or thigh administration of Lantus.
Koncentracija insulina ali glukoze v serumu se klinično ne razlikujeta pomembno, če je zdravilo Lantus injicirano v trebuh, deltoidni predel ali stegno.
The Lantus cartridges are to be used only with the pens: ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO, JuniorSTAR.
Vložki zdravila Lantus se uporabljajo samo z injekcijskimi peresniki ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO, JuniorSTAR.
Each ml of the solution contains 100 units of insulin glargine (equivalent to 3.64 mg).
En ml raztopine vsebuje 100 enot insulina glargin (ekvivalentno 3,64 mg).
How to handle SoloStar
Ravnanje z injekcijskim peresnikom SoloStar
Solution for injection 1 cartridge of 3 ml.
raztopina za injiciranje 1 vložek s 3 ml.
10 ml vial 3 years.
10 ml viala: 3 leta
LABEL (5 ml vial)
NALEPKA (5 ml viala)
Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections
Klorovodikova kislina (za uravnavanje pH) Natrijev hidroksid (za uravnavanje pH) Voda za injekcije
Lantus in cartridges is only suitable for injecting just under the skin using a reusable pen (see also section 3).
Zdravilo Lantus v vložku je primerno samo za injiciranje tik pod kožo z injekcijskim peresnikom za večkratno uporabo (glejte tudi poglavje 3).
- supplies of insulin, needles etc., - correct storage of your insulin while travelling, - timing of meals and insulin administration while travelling, - the possible effects of changing to different time zones, - possible new health risks in the countries to be visited, - what you should do in emergency situations when you feel unwell or become ill.
- pravilno shranjevanje insulina med potovanjem, - časovni razpored obrokov in dajanje insulina med potovanjem, - možni vplivi spremembe časovnih pasov, - možna nova zdravstvena tveganja v državah, ki jih boste obiskali, - kaj storiti v nujnih primerih, ko se ne počutite dobro ali zbolite.
You must check that your insulin pen is working properly before you inject the first dose.
Preden injicirate prvi odmerek, morate preveriti, da insulinski injekcijski peresnik deluje pravilno.
If administration by syringe is necessary, a vial should be used (see section 4.2).
Če je potrebno dajanje z injekcijsko brizgo, je treba uporabiti vialo (glejte poglavje 4.2).
If administration by syringe is necessary, a vial should be used (see section 4.4).
Če je potrebno dajanje z injekcijsko brizgo, je treba uporabiti vialo (glejte poglavje 4.4).
Lantus in pre-filled pen is only suitable for injecting just under the skin.
Zdravilo Lantus v napolnjenem injekcijskem peresniku je primerno samo za injiciranje tik pod kožo.
- the availability of your insulin in the country you are visiting, - supplies of insulin, needles etc., - correct storage of your insulin while travelling, - timing of meals and insulin administration while travelling, - the possible effects of changing to different time zones, - possible new health risks in the countries to be visited, - what you should do in emergency situations when you feel unwell or become ill.
Med vprašanji, o katerih se boste morali pogovoriti, so - dosegljivost vašega insulina v državi, v katero se odpravljate, - zaloge insulina,igel itd., - pravilno shranjevanje insulina med potovanjem, - časovni razpored obrokov in dajanje insulina med potovanjem, - možni vplivi spremembe časovnih con, - možna nova zdravstvena tveganja v državah, ki jih boste obiskali, - kaj storiti v nujnih primerih, ko se ne počutite dobro ali zbolite.
LABEL (10 ml vial)
NALEPKA (10 ml viala)
HbA1c changes from baseline were similar between treatment groups; however blood glucose values recorded overnight were significantly higher in the insulin glargine/ lispro group than the NPH/regular group, with a mean nadir of 5.4 mM versus 4.1 mM.
Toda vrednosti glukoze v krvi čez noč so bile v skupini z insulinom glargin in insulinom lispro značilno večje kot v skupini z insulinom NPH in navadnim insulinom; povprečna najnižja vrednost je bila v prvi skupini 5,4 mM in v drugi 4,1 mM.
The exposure to M1 increases with the administered dose of Lantus.
Glavna spojina v plazmi je presnovek M1. Izpostavljenost presnovku M1 se povečuje z uporabljenim odmerkom zdravila Lantus.
- If you are not eating enough your blood sugar level may become too low (hypoglycaemia).
Če ne jeste dovolj, se lahko koncentracija krvnega sladkorja preveč zniža (hipoglikemija).
Do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after “EXP”.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti , ki je naveden na škatli in nalepki viale poleg oznake “EXP”.
Use this medicine exactly as your doctor has told you.
Pri uporabi tega zdravila natančno upoštevajte navodila svojega zdravnika.
EU/1/00/134/031 3 pens of 3 ml EU/1/00/134/032 4 pens of 3 ml EU/1/00/134/033 5 pens of 3 ml EU/1/00/134/034 6 pens of 3 ml EU/1/00/134/035 8 pens of 3 ml EU/1/00/134/036 9 pens of 3 ml EU/1/00/134/037 10 pens of 3 ml
EU/1/00/134/033 5 injekcijskih peresnikov s 3 ml EU/1/00/134/034 6 injekcijskih peresnikov s 3 ml EU/1/00/134/035 8 injekcijskih peresnikov s 3 ml EU/1/00/134/036 9 injekcijskih peresnikov s 3 ml EU/1/00/134/037 10 injekcijskih peresnikov s 3 ml
3 pens of 3 ml 4 pens of 3 ml 5 pens of 3 ml 6 pens of 3 ml 8 pens of 3 ml 9 pens of 3 ml 10 pens of 3 ml
8 injekcijskih peresnikov s 3 ml 9 injekcijskih peresnikov s 3 ml 10 injekcijskih peresnikov s 3 ml
8 cartridges of 3 ml.
8 vložkov s 3 ml.
Do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after “EXP”.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti , ki je naveden na škatli in na nalepki injekcijskega peresnika poleg oznake “EXP”.
Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic medicinal products (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors.
Med zdravili, ki lahko zmanjšajo učinek znižanja glukoze v krvi, so kortikosteroidi, danazol, diazoksid, diuretiki, glukagon, izoniazid, estrogeni in progestogeni, fenotiazinski derivati, somatropin, simpatikomimetiki (npr. adrenalin, salbutamol, terbutalin), ščitnični hormoni, atipični antipsihotiki (npr. klozapin in olanzapin) in zaviralci proteaz.
EU/1/00/134/030 1 pen of 3 ml.
EU/1/00/134/013 1 vložek s 3 ml.
The cartridge in use must not be stored in a refrigerator.
Vložka, ki ga uporabljate, ne smete shranjevati v hladilniku.
1 ml contains 100 units (3.64 mg) insulin glargine.
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN 1 ml vsebuje 100 enot (3,64 mg) insulina glargin.
Lantus in cartridges is only suitable for injecting just under the skin using a reusable pen.
Zdravilo Lantus v vložku je primerno samo za injiciranje tik pod kožo z injekcijskim peresnikom za večkratno uporabo.
Talk with your doctor, pharmacist or nurse about proper injection technique before using SoloStar.
Preden začnete uporabljati SoloStar, se s svojim zdravnikom, s farmacevtom ali z medicinsko sestro pogovorite o pravilni tehniki injiciranja.
- If you have injected too much Lantus, your blood sugar level may become too low (hypoglycaemia).
- Če ste injicirali preveč zdravila Lantus, se vam lahko koncentracija krvnega sladkorja preveč zniža (hipoglikemija).
Before first use, the pre-filled pen must be stored at room temperature for 1 to 2 hours.
Pred prvo uporabo mora biti injekcijski peresnik 1 do 2 uri na sobni temperaturi.
Lantus is a long-acting insulin.
Zdravilo Lantus je dolgodelujoč insulin.
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen Type 1 colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with a stopper (bromobutyl or laminate of polyisoprene and bromobutyl rubber) containing 3 ml of solution.
Lantus SoloStar 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku Vložki iz brezbarvnega stekla tipa 1 s črnim batom (iz brombutilne gume) s prirobljeno zaporko (iz aluminija), z zamaškom (iz brombutilne gume ali laminata poliizoprena in brombutila), ki vsebujejo 3 ml raztopine.
Common reported side effects (may affect up to 1 in 10 people)
Pogosto poročani neželeni učinki (pojavijo se lahko pri največ 1od 10 bolnikov)
The pen containing a cartridge or the pens in use must not be stored in the refrigerator.
Injekcijskega peresnika z vstavljenim vložkom ali injekcijskih peresnikov ne smete shranjevati v hladilniku.
Each pen contains 3 ml of solution for injection (equivalent to 300 units).
En vložek vsebuje 3 ml raztopine za injiciranje (ekvivalentno 300 enot).
A 24-week parallel group study was conducted in 125 children with type 1 diabetes mellitus aged 2 to 6 years, comparing insulin glargine given once daily in the morning to NPH insulin given once or twice daily as basal insulin.
Opravljena je bila 24-tedenska študija za primerjavo bazalnih insulinov, tj. insulina glargin, ki so ga uporabljali enkrat na dan (zjutraj) in insulina NPH, ki so ga uporabljali enkrat ali dvakrat na dan.
Examples include: - you have not injected your insulin or not injected enough, or if it has become less effective,for example through incorrect storage, - you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever, - you are taking or have taken certain other medicines (see section 2, "Other medicines and
Primeri: insulina niste injicirali, ga niste injicirali dovolj ali je postal manj učinkovit, na primer zaradi nepravilnega shranjevanja, ste manj dejavni kot ponavadi, ste v stresu (čustvene stiske, vznemirjenost) ali ste poškodovani, imate operacijo, okužbo ali vročino, uporabljate ali ste uporabljali določena druga zdravila (glejte poglavje 2, "Druga zdravila in zdravilo Lantus").
Lantus SoloStar solution for injection in a pre-filled pen.
Lantus SoloStar raztopina za injiciranje v napolnjenem injekcijskem peresniku.
Tell a doctor straight away if you notice signs of severe allergic reaction.
Če opazite znake hude alergijske reakcije se o tem takoj posvetujte z zdravnikom.
In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism.
Okvara ledvic Bolnikom z okvaro ledvic se lahko potreba po insulinu zmanjša zaradi zmanjšane presnove insulina.
Once in use, the 5 ml vial may be stored for a maximum of 4 weeks in the outer carton not above 25°C and away from direct heat or direct light.
Ko 5 ml vialo začnete uporabljati, jo lahko shranjujete največ 4 tedne v zunanji ovojnini pri temperaturi do 25°C in zaščiteno pred neposredno toploto ali svetlobo.
The medicinal product may be stored for a maximum of 4 weeks not above 25°C and away from direct heat or direct light.
Zdravilo lahko shranjujete največ 4 tedne pri temperaturi do 25°C in zaščiteno pred neposredno toploto ali svetlobo.
Lantus 100 units/ml solution for injection in a cartridge Type 1 colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with a stopper (bromobutyl or laminate of polyisoprene and bromobutyl rubber) containing 3 ml of solution.
Lantus 100 enot/ml raztopina za injiciranje v vložku Vložki iz brezbarvnega stekla tipa 1 s črnim batom (iz brombutilne gume) s prirobljeno zaporko (iz aluminija), z zamaškom (iz brombutilne gume ali laminata poliizoprena in brombutila), ki vsebujejo 3 ml raztopine.
Lantus SoloStar
PODATKI V BRAILLOVI PISAVI Lantus SoloStar
Lantus comes in a special cartridge to be used only in conjunction with the pens ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO or JuniorSTAR.
Zdravilo Lantus je na voljo v posebnih vložkih, ki se uporabljajo samo skupaj z injekcijskimi peresniki ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO ali JuniorSTAR.
Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany.
Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Nemčija.
5 vials of 5 ml.
5 vial s 5 ml.
It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency.
Uporabite jo le, če je raztopina v njej bistra, brezbarvna, ne vsebuje vidnih trdnih delcev in je vodi podobne konsistence.
Alternative site 10 ml vials:
10 ml viala:
You must always check the insulin label before each injection to avoid mix-ups between Lantus and other insulins.
Da bi se izognili zamenjavi med zdravilom Lantus in drugimi insulini, vedno pred vsakim injiciranjem preverite nalepko insulina.
The medicinal product may be stored for a maximum of 4 weeks not above 30°C and away from direct heat or direct light.
Zdravilo lahko shranjujete največ 4 tedne pri temperaturi do 30°C in zaščiteno pred neposredno toploto ali svetlobo.
- The other ingredients are: zinc chloride, metacresol, glycerol, sodium hydroxide (see section 2 “Important information about some of the ingredients of Lantus”) and hydrochloric acid (for pH adjustment), polysorbate 20 (10 ml vial only) and water for injections.
- Pomožne snovi so: cinkov klorid, meta-krezol, glicerol, natrijev hidroksid (glejte poglavje 2 “Pomembne informacije o nekaterih sestavinah zdravila Lantus”) in klorovodikova kislina (za uravnavanje pH), polisorbat 20 (samo 10-ml viale) in voda za injekcije.
In healthy subjects and diabetic patients, insulin serum concentrations indicated a slower and much more prolonged absorption and showed a lack of a peak after subcutaneous injection of insulin glargine in comparison to human NPH insulin.
Koncentracija insulina v serumu pri zdravih preiskovancih in diabetikih je po subkutani injekciji insulina glargin v primerjavi s humanim insulinom NPH pokazala počasnejšo in mnogo dolgotrajnejšo absorpcijo ter ni imela vrha.
There is no experience with the use of Lantus in children below the age of 2 years.
Pri otrocih, mlajših od 2 let, izkušenj z uporabo zdravila Lantus ni.
Once in use, the 10 ml vial may be stored for a maximum of 4 weeks in the outer carton not above 30°C and away from direct heat or direct light.
Ko 10 ml vialo začnete uporabljati, jo lahko shranjujete največ 4 tedne v zunanji ovojnini pri temperaturi do 30°C in zaščiteno pred neposredno toploto ali svetlobo.
You may need to talk about - the availability of your insulin in the country you are visiting,
Med vprašanji, o katerih se boste morali pogovoriti, so - dosegljivost vašega insulina v državi, v katero se odpravljate, - zaloge insulina, injekcijskih brizg itd.,
See the reverse (insulin) side of this leaflet for instructions on how to store SoloStar.
Za navodila o shranjevanju SoloStarja glejte hrbtno stran (stran o insulinu) tega navodila.
10 vials of 5 ml.
10 vial s 5 ml.
Type 1 colourless glass vial with a flanged cap (aluminium), a stopper (type 1, laminate of polyisoprene and bromobutyl rubber) and a tear-off cap (polypropylene) containing 10 ml of solution.
Viala iz brezbarvnega stekla tipa 1 s prirobljeno zaporko (iz aluminija), z zamaškom (tip 1, iz poliizoprenskega laminata in brombutilne gume) in s pokrovčkom, ki se odtrga (iz polipropilena), ki vsebuje 10 ml raztopine.
Type 1 colourless glass vial with a flanged cap (aluminium), a stopper (chlorobutyl rubber (type 1)) and a tear-off cap (polypropylene) containing 5 ml of solution.
Viala iz brezbarvnega stekla tipa 1 s prirobljeno zaporko (iz aluminija), z zamaškom (iz klorobutilne gume (tipa 1)) in s pokrovčkom, ki se odtrga (iz polipropilena), ki vsebuje 5 ml raztopine.
A. Use the injection method as instructed by your doctor, pharmacist or nurse.
5. korak Injicirajte odmerek A. Uporabite postopek injiciranja, ki vam ga je pokazal zdravnik, farmacevt ali medicinska sestra.
Each ml contains 100 units insulin glargine* (equivalent to 3.64 mg).
KAKOVOSTNA IN KOLIČINSKA SESTAVA En mililiter vsebuje 100 enot insulina glargin* (kar ustreza 3,64 mg).
Before insertion into the pen, the cartridge must be stored at room temperature for 1 to 2 hours.
Preden vstavite vložek v injekcijski peresnik, ga morate pustiti na sobni temperaturi 1 do 2 uri.
Hypoglycaemia is also more likely to occur if - you have just begun insulin treatment or changed to another insulin preparation (when changing from your previous basal insulin to Lantus hypoglycaemia, if it occurs, may be more likely to occur in the morning than at night), - your blood sugar levels are almost normal or are unstable, - you change the area of skin where you inject insulin (for example from the thigh to the upper arm), - you suffer from severe kidney or liver disease, or some other disease such as hypothyroidism.
Hipoglikemija je verjetnejša tudi, če - ste pravkar začeli zdravljenje z insulinom ali ste prešli na drug pripravek insulina (po prehodu s predhodnih bazalnih insulinov na zdravilo Lantus je hipoglikemija, če se pojavi, verjetnejša zjutraj kot ponoči), - je koncentracija vašega krvnega sladkorja skoraj normalna ali ni stabilna, zamenjate predel kože, kamor injicirate insulin (na primer s stegna na nadlaket),
Lantus 100 units/ml solution for injection in a vial 5 ml vial
Lantus 100 enot/ml raztopina za injiciranje v viali 5 ml viala:
The cartridge is sealed in a disposable pen injector.
Vložek je zapečaten v injekcijskem peresniku za enkratno uporabo.
OUTER CARTON (cartridge)
ZUNANJA OVOJNINA (vložek)
See the box at the end of this leaflet for further information.
Glejte okvir na koncu tega navodila za uporabo.
This medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially ‘sodium-free'.
Pomembne informacije o nekaterih sestavinah zdravila Lantus To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni brez natrija.
Medicines that may cause your blood sugar level to fall (hypoglycaemia) include: - all other medicines to treat diabetes, - angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure), - disopyramide (used to treat certain heart conditions), - fluoxetine (used to treat depression), - fibrates (used to lower high levels of blood lipids), - monoamine oxidase (MAO) inhibitors (used to treat depression), - pentoxifylline, propoxyphene, salicylates (such as acetylsalicylic acid, used to relieve pain and lower fever), - sulfonamide antibiotics.
Med zdravili, ki lahko povzročijo znižanje koncentracije krvnega sladkorja (hipoglikemija) so: vsa druga zdravila za zdravljenje sladkorne bolezni, zaviralci angiotenzinske konvertaze (ACE - angiotensin converting enzyme) (uporabljajo se za zdravljenje določenih bolezenskih stanj srca ali visokega krvnega tlaka), dizopiramid (uporablja se za zdravljenje določenih bolezenskih stanj srca), fluoksetin (uporablja se za zdravljenje depresije), fibrati (uporabljajo se za zniževanje visokih koncentracij krvnih lipidov), zaviralci monoaminooksidaze (MAO) (uporabljajo se za zdravljenje depresije), pentoksifilin, propoksifen, salicilati (na primer acetilsalicilna kislina, uporabljajo se za lajšanje bolečine in znižanje zvišane telesne temperature), sulfonamidni antibiotiki.
- If you are allergic to insulin glargine or to any of the other ingredients of this medicine (listed in section 6).
Kaj morate vedeti, preden boste uporabili zdravilo Lantus Ne uporabljajte zdravila Lantus - Če ste alergični na insulin glargin ali katero koli sestavino tega zdravila (navedeno v poglavju
- The other ingredients are: zinc chloride, metacresol, glycerol, sodium hydroxide (see section 2 “Important information about some of the ingredients of Lantus”) and hydrochloric acid (for pH adjustment) and water for injections.
- Pomožne snovi so: cinkov klorid, meta-krezol, glicerol, natrijev hidroksid (glejte poglavje 2 “Pomembne informacije o nekaterih sestavinah zdravila Lantus”) in klorovodikova kislina (za uravnavanje pH) in voda za injekcije.
Lantus 100 units/ml solution for injection in a vial is a clear, colourless and waterlike solution.
Lantus 100 enot/ml, raztopina za injiciranje v viali, je bistra, brezbarvna raztopina, podobna vodi.
Remove and discard the needle
6. korak Iglo odstranite in zavrzite
Excipients: zinc chloride, metacresol, glycerol, hydrochloric acid and sodium hydroxide (for pH adjustment), polysorbate 20, , water for injections.
Pomožne snovi: cinkov klorid, metakrezol, glicerol, klorovodikova kislina natrijev hidroksid (za uravnavanje pH), polisorbat 20, voda za injekcije.
Once in use, vials may be stored for a maximum of 4 weeks not above 25°C.
Ko viale začnete uporabljati, jih lahko shranjujete največ 4 tedne pri temperaturi do 25°C.
You may need to talk about
On vam bo povedal, kaj je potrebno storiti.
Very rare reported side-effects (may affect up to1 in10,000 people) In very rare cases, dysgeusia (taste disorders) and myalgia (muscular pain) can occur.
V zelo redkih primerih se lahko pojavita dizgevzija (motnje okušanja) in mialgija (bolečine v mišicah).
Before using the pre-filled pen, the instructions for use included in the package leaflet must be read carefully.
Pred uporabo SoloStarja natančno preberite navodila za ravnanje z injekcijskim peresnikom v navodilu za uporabo.
Packs of 1, 3, 4, 5, 6, 8, 9 and 10 cartridges.
Pakiranja z 1, 3, 4, 5, 6, 8, 9 in 10 vložki.
Packs of 1, 3, 4, 5, 6, 8, 9 and 10 SoloStar pre-filled pens.
Pakiranja z 1, 3, 4, 5, 6, 8, 9 in 10 Solostar napolnjenimi injekcijskimi peresniki.
If your blood sugar level falls too low, you may pass out (become unconscious).
Če se vam koncentracija krvnega sladkorja preveč zniža, lahko izgubite zavest.
Each cartridge contains 3 ml of solution for injection (equivalent to 300 units).
En injekcijski peresnik vsebuje 3 ml raztopine za injiciranje (ekvivalentno 300 enot).
Marketing Authorisation Holder Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany.
IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Nemčija.
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main, Germany.
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main Nemčija
PEN LABEL (Pre-filled pen.SoloStar)
ZUNANJA OVOJNINA (Napolnjen injekcijski peresnik SoloStar)